This article was originally published in The Gray Sheet
Next-generation Lifepath endovascular graft system for abdominal aortic aneurysms, which uses stronger "wireform" supports, gains CE mark approval for European marketing. In April 2000, Edwards suspended sales of a first-generation system outside the U.S., as well as clinical trials worldwide, following fractures in the wire scaffolding
You may also be interested in...
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.
A few months after bringing AstraZeneca onboard as a partner, the turnaround at the Alderley Park-based firm is moving ahead, buoyed by a fresh financing.
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.